Gamma Pharmaceuticals signs Distribution Agreement for its branded product ranges

Jan 21 2010

Gamma Pharmaceuticals Inc. (PINKSHEETS: GMPM) announced today that the Company has signed a Distribution Agreement for Gamma's branded product ranges. Under the Distribution Agreement, Gamma's monthly sales will ramp-up to $3.4 million. The first monthly purchase order has been accepted with a value of $1.03 million. The Agreement marks a significant milestone for Gamma, as it provides a key piece in the Company's North American Distribution plan. Gamma offers the industry's most distinctive blend of brands, product forms, marketing programs and market message all focused on moving products through large and profitable sales channels. The order received includes the Company's proprietary GELIbites®, GELIthins® and GELIcreams®.

Peter Cunningham, Gamma CEO, commented, "We are very excited to have contracted with such a capable partner and are working diligently to piece together a distribution network that will drive high volume, high value sale for years to come. We feel that 2010 will be a game changer for Gamma in every respect as we deliver on our potential and drive shareholder value. We have a deep sales pipeline that we will fill in the weeks and months ahead."